We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Vascular Compression Devices Reduce Thrombus Formation

By HospiMedica International staff writers
Posted on 15 Mar 2012
Novel vascular compression devices decrease the incidence of deep vein thrombosis (DVT) formation in patients at risk.

The Flowtron range of intermittent pneumatic compression (IPC) devices mimic the natural physiological muscle pump created during walking, thus increasing both the volume and rate of blood flow through the limb, and eliminating venous stasis. More...
The use of the IPC device also delivers dual benefits of suppressing procoagulant activation and enhancing global fibrinolysis. The system has a simple three-in-one design that provides a choice of foot, calf, or thigh compression from a single pump. A fail-safe feature offers single and dual compression; if a problem is detected on one side, compression continues on the other.

The system is designed to achieve a high level of patient acceptance by using an ultra-quiet pump for noise reduction and lightweight, breathable fabrics that provide maximum comfort by preventing build-up of heat and moisture. Other features of the systems include auto garment recognition (the system adjusts pressure automatically according to garment type), hook and loop fixings to ensure a secure and snug fit, and a liquid crystal display (LCD) user interface that provides instant feedback, clearly indicating system set-up, therapy status, and actual pressure delivered. An integrated battery maintains prophylaxis during patient transport. The Flowtron range of IPC devices are a product of ArjoHuntleigh (Lund, Sweden).

DVT commonly affects the leg veins (such as the femoral vein, the popliteal vein, or the iliofemoral vein), or the deep veins of the pelvis. A DVT can occur without symptoms, but in many cases, the affected extremity will be painful, swollen, red, and warm, and the superficial veins may be engorged. The most serious complication of a DVT is that the clot could dislodge and travel to the lungs, which is called a pulmonary embolism (PE). DVT is a medical emergency and untreated lower extremity DVT has a 3% PE-related mortality rate.

Related Links:

ArjoHuntleigh



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Xenon Light Source
CLV-S400
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.